Cachet Pharmaceutical Co., Ltd.

SZSE:002462 Rapport sur les actions

Capitalisation boursière : CN¥3.3b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Cachet Pharmaceutical Croissance future

Future contrôle des critères 0/6

Cachet Pharmaceutical is forecast to grow revenue at 0.2% per annum.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Healthcare croissance des bénéfices21.2%
Taux de croissance des recettes0.2%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour06 Mar 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Cachet Pharmaceutical's (SZSE:002462) Dividend Will Be Reduced To CN¥0.26

Jun 23
Cachet Pharmaceutical's (SZSE:002462) Dividend Will Be Reduced To CN¥0.26

Cachet Pharmaceutical's (SZSE:002462) Soft Earnings Are Actually Better Than They Appear

May 05
Cachet Pharmaceutical's (SZSE:002462) Soft Earnings Are Actually Better Than They Appear

Prévisions de croissance des bénéfices et des revenus

SZSE:002462 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202530,642N/AN/AN/A1
12/31/202429,183N/AN/AN/A1
3/31/202430,6832589711,169N/A
12/31/202329,9962501,3961,595N/A
9/30/202327,7272871,2291,416N/A
6/30/202328,3912831,6591,845N/A
3/31/202326,5152861,0331,220N/A
1/1/202326,220297-352-163N/A
9/30/202226,555335-2427N/A
6/30/202225,770348-575-324N/A
3/31/202226,276351-23316N/A
12/31/202125,626354666913N/A
9/30/202126,318338699958N/A
6/30/202126,106357656918N/A
3/31/202125,0183481,2741,531N/A
12/31/202023,2563188571,115N/A
9/30/202022,670325183260N/A
6/30/202021,660300256469N/A
3/31/202021,396328-123143N/A
12/31/201922,18737631293N/A
9/30/201920,601363302510N/A
6/30/201919,67935462129N/A
3/31/201919,011339173193N/A
12/31/201817,960328-313-292N/A
9/30/201817,181323-1,151-1,127N/A
6/30/201816,223306-431-406N/A
3/31/201814,997280-728-705N/A
12/31/201714,239264N/A-374N/A
9/30/201713,270253N/A478N/A
6/30/201712,395250N/A-105N/A
3/31/201711,578240N/A197N/A
12/31/201610,972223N/A116N/A
9/30/201610,320211N/A131N/A
6/30/20169,628199N/A-171N/A
3/31/20168,922189N/A-639N/A
12/31/20158,200173N/A-310N/A
9/30/20157,540166N/A-872N/A
6/30/20156,871158N/A-839N/A
3/31/20156,188142N/A-673N/A
12/31/20145,572228N/A-764N/A
9/30/20144,976243N/A-675N/A
6/30/20144,342231N/A-413N/A
3/31/20143,907236N/A-353N/A
12/31/20133,544130N/A-312N/A
9/30/20133,12489N/A59N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if 002462's forecast earnings growth is above the savings rate (2.9%).

Bénéfices vs marché: Insufficient data to determine if 002462's earnings are forecast to grow faster than the CN market

Croissance élevée des bénéfices: Insufficient data to determine if 002462's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 002462's revenue (0.2% per year) is forecast to grow slower than the CN market (13.4% per year).

Croissance élevée des revenus: 002462's revenue (0.2% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if 002462's Return on Equity is forecast to be high in 3 years time

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y